Guanabenz
Wytensin (guanabenz) is a small molecule pharmaceutical. Guanabenz was first approved as Wytensin on 1982-09-07. It is used to treat hypertension in the USA. The pharmaceutical is active against alpha-2A adrenergic receptor, alpha-2B adrenergic receptor, and alpha-2C adrenergic receptor.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
cardiovascular diseases | D002318 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Guanabenz acetate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
WYTENSIN | Wyeth | N-018587 DISCN | 1982-09-07 | 3 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hypertension | EFO_0000537 | D006973 | I10 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | GUANABENZ |
INN | guanabenz |
Description | Guanabenz is a dichlorobenzene. |
Classification | Small molecule |
Drug class | antihypertensives (guanidine deriviatives); cannabinol derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | N=C(N)N/N=C/c1c(Cl)cccc1Cl |
Identifiers
PDB | — |
CAS-ID | 5051-62-7 |
RxCUI | 5033 |
ChEMBL ID | CHEMBL420 |
ChEBI ID | 5553 |
PubChem CID | 5702063 |
DrugBank | DB00629 |
UNII ID | GGD30112WC (ChemIDplus, GSRS) |
Target
Agency Approved
ADRA2A
ADRA2A
ADRA2B
ADRA2B
ADRA2C
ADRA2C
Organism
Homo sapiens
Gene name
ADRA2A
Gene synonyms
ADRA2R, ADRAR
NCBI Gene ID
Protein name
alpha-2A adrenergic receptor
Protein synonyms
adrenergic, alpha-2A-, receptor, Alpha-2 adrenergic receptor subtype C10, alpha-2-adrenergic receptor, platelet type, Alpha-2A adrenoceptor, Alpha-2A adrenoreceptor, Alpha-2AAR, alpha-2AAR subtype C10
Uniprot ID
Mouse ortholog
Adra2a (11551)
alpha-2A adrenergic receptor (Q3URE6)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 919 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
4 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more